BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Shares the Gift of Good News for Breast Cancer Patients at World’s Largest Breast Cancer Conference
Breast cancer is the leading cancer diagnosed in women, with more than two million new cases diagnosed this year BriaCell Therapeutics advancing prospects of its trademarked Bria-IMT immunotherapy treatment for breast cancer in phase I/IIa trial Company presented data from ongoing trial during San Antonio Breast Cancer Symposium, one of the largest breast cancer conferences in the world The holidays can be a particularly poignant time for receiving a cancer diagnosis as all of society celebrates a season of cheer and shares goodwill with each other, but the San Antonio Breast Cancer Symposium (SABCS), one of the largest breast cancer…